CSF3 and Miyoshi myopathy: The pooled results in our meta-analysis also showed a favorable EFS (HR = 0.73, p = 0.01) and a better 3-year EFS rate (OR = 1.65, p = 0.02) in the CTX plus G-CSF group, which indicated that the CTX plus G-CSF mobilization schedule was advantageous to benefit patients with MM remaining event-free after ASCT.